NCT05112965 2026-01-07An Extension Study in Participants Previously Enrolled in a Genentech and/or F. Hoffmann-La Roche Ltd Sponsored Atezolizumab Study (IMbrella C)Hoffmann-La RochePhase 3 Active not recruiting49 enrolled